Christopher Benecchi

Corporate Officer/Principal at SAGE THERAPEUTICS, INC.

Net worth: 80 529 $ as of 2024-04-29

Health Technology

Consumer Services

Finance

Christopher Benecchi active positions

Companies	Position	Start	End
SAGE THERAPEUTICS, INC.	Corporate Officer/Principal	2021-09-20	-

Companies	Position	Start	End
ALEXION PHARMACEUTICALS, INC.	Corporate Officer/Principal	2019-07-31	2021-08-31
UCB, Inc. UCB, Inc. Financial ConglomeratesFinance Part of UCB SA, UCB, Inc. provides financial services. The company is based in Smyrna, GA. The CEO of the company is Duane Barnes.	Corporate Officer/Principal	2011-07-31	2019-07-31

Duke University	Masters Business Admin
Colby College	Undergraduate Degree

International

United States

Operational

Corporate Officer/Principal	3
Masters Business Admin	1
Undergraduate Degree	1

Sectoral

Positions held

Active

Inactive

Listed companies

Private companies

Listed companies	1
SAGE THERAPEUTICS, INC.	Health Technology

Private companies	2
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA.	Health Technology
UCB, Inc. UCB, Inc. Financial ConglomeratesFinance Part of UCB SA, UCB, Inc. provides financial services. The company is based in Smyrna, GA. The CEO of the company is Duane Barnes.	Finance

Private companies

Health Technology

Finance